Cures Act

FDA Partners with COTA Inc. to Embrace Real-World Evidence for Breast Cancer Insights

Jul 10, 2019 | Breast Cancer, Cures Act, FDA, Oncology, Real-world data, Real-World Evidence, RWD, RWE

COTA, Inc. positions itself as a leading precision medicine technology company utilizing real-world evidence to bring clarity to cancer care, recently announced it has signed a two-year Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

FDA Partners with COTA Inc. to Embrace Real-World Evidence for Breast Cancer Insights

Pin It on Pinterest